Dr. Carolyn Ng is Vice President of Vertex Ventures HC, the venture capital arm of Temasek Holdings specializing in early stage life sciences investments globally. At Vertex, Dr. Ng is responsible for evaluating and driving venture investments across health tech, biotechnology, and medical device fields. Oncology scientist by background, Dr. Ng is passionate about innovation that impacts patients’ lives. Dr. Ng works closely with entrepreneurs, community leaders, life science corporations, and government bodies in shaping a strong and vibrant healthcare startup ecosystem in Singapore. Prior to joining Vertex, Carolyn was a Strategy Consultant at Deallus Consulting, a specialized London-headquartered life sciences consulting firm with clientele comprised of the top 20 global pharmaceutical companies.
Dr. Carolyn Ng holds a PhD in Cancer Molecular Biology from the NUS Graduate School for Integrative Sciences and Technology (NGS), where she was a recipient of the prestigious NGS PhD Scholarship. During her academic career, she was a co-inventor of a novel small molecule nuclear receptor activator indicated for the treatment of neuroblastoma. She also holds a BS (Pharmacy) (First Class Honours) degree from the National University of Singapore.
Notice: This person is attending Slush or has done so in the past. Description last updated Aug 19, 2017